CELL-BASED


TECHNOLOGY


PLATFORMS


2023 Annual Report




...

Related Keywords

Israel , China , United States , Japan , Washington , Germany , South Korea , National Institutes Of Health , Maryland , Nevada , Israeli , State Of Israel , America , Pluristem Gmb , , Technology Park , Tnuva Food Industries , European Union Horizon , Securities Exchange , Exchange Commission , Pluri Biotech Ltd , Tel Aviv Sourasky Medical Center Ichilov Hospital , Uniformed Services University Of Health Sciences , Japan Pharmaceuticals , Paul Ehrlich Institute , Israel Ltd , Devices Agency , Our Technology , Dod Armed Forces Radiobiology Research Institute , Pluri Health , Foods Ltd , Us National Institute Of Allergy , Plurinuva Ltd , Ministry Of Food , Clinical Affairs Strategy , European Medicine Agency , Data Monitoring Committee , Us Department Of Defense , Technology Collaboration The Biologics Field , Pluri Inc , Access Program , Tel Aviv Sourasky Medical Center , Israel Innovation Authority , Our Clinical Development Product Candidates , Drug Administration , Mark One , Zip Code , Securities Exchange Act , Interactive Data File , Regulations T , Sarbanes Oxley Act , Common Equity , Related Stockholder Matters , Issuer Purchases , Equity Securities , Financial Condition , Qualitative Disclosures About Market Risk , Supplementary Data , Disagreements With Accountants , Financial Disclosure , Regarding Foreign Jurisdictions , Prevent Inspections , Executive Officers , Corporate Governance , Certain Beneficial Owners , Related Transactions , Director Independence , Accounting Fees , United States Dollars , Annual Report , Private Securities Litigation Reform Act , European Union , National Institutes , Good Manufacturing Practice , Tnuva Food Tech Incubator , Limited Partnership , Chronic Graft , Host Disease , Hematopoietic Acute Radiation Syndrome , Infectious Diseases , Armed Forces Radiobiology Research Institute , Uniformed Services University , Health Sciences , United Statesa , Ever After Foods Ltd , Ever After Foods , Pluristem Gmbh , Current Good Manufacturing Practice , Short Physical Performance Battery , Hip Abduction Strength , Acute Respiratory Distress Syndrome , Investigational New Drug Application , Expanded Access Program , Parallel Group Phase , Intramuscular Injections , Rutherford Category , Biologics License Application , Investigational New Drug , Ichilov Hospital , Medical Devices Agency , Drug Safety , Food Tech Sector , After Foods , Joint Venture Agreement , Licensed Products , Closing Date , Biologics Field , Far East , South America , Markets ,